Playez
I obviously do not know who is developing the in house daptomycin injectable development plan.For all I know it could be being developed in consultation with a potential partner.As far as I am concerned this product this product is at the make or break stage for POH.
Kens
Ann: Updated Presentation to Support CEO Partnering Meetings, page-28
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add POH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| POH (ASX) Chart |
Day chart unavailable
